Comparative Analysis Between the HER2 Status in Primary Breast Cancer Tissue and the Detection of Isolated Tumor Cells in the Bone Marrow
- 1 September 2004
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 87 (1) , 65-74
- https://doi.org/10.1023/b:brea.0000041583.72269.e1
Abstract
The presence of isolated tumor cells in the bone marrow (ITC-BM) of breast cancer patients is an independent prognostic parameter, indicating hematogenous tumor cell dissemination. While the HER2...Keywords
This publication has 34 references indexed in Scilit:
- Detection of Isolated Tumor Cells in Bone Marrow Is an Independent Prognostic Factor in Breast CancerJournal of Clinical Oncology, 2003
- The ErbB receptors and their role in cancer progressionExperimental Cell Research, 2003
- The clinical evaluation of HER‐2 status: which test to use?The Journal of Pathology, 2003
- Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by IrradiationNew England Journal of Medicine, 2002
- Molecular Determinants of Occult Metastatic Tumor Cells in Bone MarrowClinical Breast Cancer, 2001
- Testing for HER2 StatusOncology, 2001
- UK and USA breast cancer deaths down 25% in year 2000 at ages 20–69 yearsPublished by Elsevier ,2000
- Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast CancerNew England Journal of Medicine, 2000
- Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up studyThe Lancet, 1999
- Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with primary tumour prognostic featuresBritish Journal of Cancer, 1994